Study of Veltuzumab (hA20) at Different Doses in Patients With ITP

Clinical trial NCT00547066 · TERMINATED

Trial details

NCT number: NCT00547066
Sponsor: Gilead Sciences
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Purpura, Thrombocytopenic, Idiopathic Autoimmune Thrombocytopenic Purpura Purpura, Thrombocytopenic, Autoimmune

Start date: 2007-11-01
Primary completion: 2011-11-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.